Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF. Issue 2 (13th July 2021) - Felker, G. Michael; Butler, Javed; Ibrahim, Nasiren E.; Piña, Ileana L.; Maisel, Alan; Bapat, Devavrat; Camacho, Alexander; Ward, Jonathan H.; Williamson, Kristin M.; Solomon, Scott D.; Januzzi, James L.